NCT05681611View on ClinicalTrials.gov

Effect of Rocuronium on BIS Values

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Breast CancerGeneral Anaesthesia
Interventions
DRUG

Rocuronium

Rocuronium bolus was administered, according to our protocol, to facilitate surgery and ventilation.

Trial Locations (1)

Unknown

ULSS2, Treviso

All Listed Sponsors
lead

University of Padova

OTHER